157 related articles for article (PubMed ID: 23633532)
1. Regulation of lipid metabolism by glucocorticoids and 11β-HSD1 in skeletal muscle.
Morgan SA; Gathercole LL; Simonet C; Hassan-Smith ZK; Bujalska I; Guest P; Abrahams L; Smith DM; Stewart PM; Lavery GG; Tomlinson JW
Endocrinology; 2013 Jul; 154(7):2374-84. PubMed ID: 23633532
[TBL] [Abstract][Full Text] [Related]
2. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
Morgan SA; Sherlock M; Gathercole LL; Lavery GG; Lenaghan C; Bujalska IJ; Laber D; Yu A; Convey G; Mayers R; Hegyi K; Sethi JK; Stewart PM; Smith DM; Tomlinson JW
Diabetes; 2009 Nov; 58(11):2506-15. PubMed ID: 19675138
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism.
Morgan SA; Hassan-Smith ZK; Doig CL; Sherlock M; Stewart PM; Lavery GG
J Endocrinol; 2016 Jun; 229(3):277-86. PubMed ID: 27048233
[TBL] [Abstract][Full Text] [Related]
4. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid reduces glucocorticoid sensitivity in C2C12 myotubes by decreasing 11beta-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor activities.
Aubry EM; Odermatt A
Endocrinology; 2009 Jun; 150(6):2700-8. PubMed ID: 19179438
[TBL] [Abstract][Full Text] [Related]
6. Cellular and genetic models of H6PDH and 11β-HSD1 function in skeletal muscle.
Zielinska AE; Fletcher RS; Sherlock M; Doig CL; Lavery GG
Cell Biochem Funct; 2017 Jul; 35(5):269-277. PubMed ID: 28749080
[TBL] [Abstract][Full Text] [Related]
7. Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue.
Gathercole LL; Morgan SA; Bujalska IJ; Hauton D; Stewart PM; Tomlinson JW
PLoS One; 2011; 6(10):e26223. PubMed ID: 22022575
[TBL] [Abstract][Full Text] [Related]
8. TNFα-mediated Hsd11b1 binding of NF-κB p65 is associated with suppression of 11β-HSD1 in muscle.
Doig CL; Bashir J; Zielinska AE; Cooper MS; Stewart PM; Lavery GG
J Endocrinol; 2014 Mar; 220(3):389-96. PubMed ID: 24413279
[TBL] [Abstract][Full Text] [Related]
9. 11β-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation.
Hardy RS; Doig CL; Hussain Z; O'Leary M; Morgan SA; Pearson MJ; Naylor A; Jones SW; Filer A; Stewart PM; Buckley CD; Lavery GG; Cooper MS; Raza K
J Pathol; 2016 Dec; 240(4):472-483. PubMed ID: 27578244
[TBL] [Abstract][Full Text] [Related]
10. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
Biedasek K; Andres J; Mai K; Adams S; Spuler S; Fielitz J; Spranger J
PLoS One; 2011 Jan; 6(1):e16674. PubMed ID: 21304964
[TBL] [Abstract][Full Text] [Related]
12. Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1.
Semjonous NM; Sherlock M; Jeyasuria P; Parker KL; Walker EA; Stewart PM; Lavery GG
Endocrinology; 2011 Jan; 152(1):93-102. PubMed ID: 21106871
[TBL] [Abstract][Full Text] [Related]
13. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal regulation of 11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro.
Michas G; Liberman M; Becker KC; Handy DE; Loscalzo J; Leopold JA
Mol Cell Biochem; 2011 Jan; 346(1-2):69-79. PubMed ID: 20922465
[TBL] [Abstract][Full Text] [Related]
15. The cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in the pathogenesis of the metabolic syndrome.
Loerz C; Maser E
J Steroid Biochem Mol Biol; 2017 Nov; 174():65-71. PubMed ID: 28765040
[TBL] [Abstract][Full Text] [Related]
16. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
[TBL] [Abstract][Full Text] [Related]
17. Methionine restriction effects on 11 -HSD1 activity and lipogenic/lipolytic balance in F344 rat adipose tissue.
Perrone CE; Mattocks DA; Hristopoulos G; Plummer JD; Krajcik RA; Orentreich N
J Lipid Res; 2008 Jan; 49(1):12-23. PubMed ID: 17909224
[TBL] [Abstract][Full Text] [Related]
18. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts.
Sun K; Myatt L
Endocrinology; 2003 Dec; 144(12):5568-77. PubMed ID: 12960005
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.
Sai S; Esteves CL; Kelly V; Michailidou Z; Anderson K; Coll AP; Nakagawa Y; Ohzeki T; Seckl JR; Chapman KE
Mol Endocrinol; 2008 Sep; 22(9):2049-60. PubMed ID: 18617597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
